In May 2024, Kura Oncology announced completion of enrollment in the Phase 2 portion of KOMET-001, a registration-directed trial of ziftomenib in patients with R/R NPM1-mutant AML. Enrollment of the ...
Today’s NYT Connections: Sports Edition hints and answers are coming right up. Connections: Sports Edition is a free daily New York Times game. You get a new puzzle at midnight every day and you can ...